BioSET uses bioactive peptides in order to communicate growth signals to damaged cells, which promotes the healing process.
Tornier will use the technology to emphasize treatment on rotator cuff, shoulder, knee, and elbow injuries. The company is working to develop a soft-tissue graft with synthetic human growth factor.
Read the R&D report on this tissue repair technology.
Read more coverage on tissue repair:
– Anulex Technologies Raises $2M for Soft Tissue Repair Product Development
– KFx Medical Receives 510(k) Clearance for Arthroscopic Knee Products
– Smith & Nephew Introduce TWINFIX Suture Anchor for Rotator Cuff Repair
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
